Literature DB >> 28600686

A critical prognostic analysis of neutrophil-lymphocyte ratio for patients undergoing nephroureterectomy due to upper urinary tract urothelial carcinoma.

Mesut Altan1, Hakan Bahadır Haberal2, Bülent Akdoğan1, Haluk Özen1.   

Abstract

BACKGROUND: To determine preoperative serum complete blood count parameters that affects survival of patients who underwent surgery for upper urinary tract urothelial cancer (UUT-UC).
METHODS: Since 1990, 150 patients underwent nephroureterectomy with bladder cuff excision for UUT-UC at Hacettepe University. Patients with a history of muscle-invasive bladder cancer, adjuvant chemotherapy or metastasis at the time of diagnosis were excluded. One hundred and thirteen patients without infective symptoms and with a full set of serum data were evaluated retrospectively. Effects of the neutrophil-lymphocyte ratio (NLR), lymphocyte-monocyte ratio (LMR), platelet-lymphocyte ratio (PLR), and leukocyte count on disease-free survival (DFS) and progression-free survival (PFS) were investigated. Threshold values for each parameter to predict PFS were calculated.
RESULTS: The mean age and median follow-up were 63.7 ± 11.1 years and 34 (3-186) months, respectively. Male to female ratio was 86/27. The 5-years PFS (bladder recurrence was excluded) and DFS were 59.6 and 38.4%, respectively. In multivariate analysis, NLR was independent prognostic factor for PFS and DFS (p = 0.006 and p = 0.021, respectively) while LMR was prognostic only for PFS (p = 0.037).
CONCLUSION: For UUT-UC, NLR is a prognostic factor for PFS and DFS, while LMR is a prognostic indicator for PFS in present series.

Entities:  

Keywords:  Complete blood count parameters; Neutrophil–lymphocyte ratio; Progression free survival; Upper urinary tract; Urothelial carcinoma

Mesh:

Year:  2017        PMID: 28600686     DOI: 10.1007/s10147-017-1150-x

Source DB:  PubMed          Journal:  Int J Clin Oncol        ISSN: 1341-9625            Impact factor:   3.402


  31 in total

Review 1.  The hallmarks of cancer.

Authors:  D Hanahan; R A Weinberg
Journal:  Cell       Date:  2000-01-07       Impact factor: 41.582

Review 2.  Prognostic factors in upper urinary tract urothelial carcinomas: a comprehensive review of the current literature.

Authors:  Giovanni Lughezzani; Maximilian Burger; Vitaly Margulis; Surena F Matin; Giacomo Novara; Morgan Roupret; Shahrokh F Shariat; Christopher G Wood; Richard Zigeuner
Journal:  Eur Urol       Date:  2012-02-23       Impact factor: 20.096

3.  Effect of preoperative chemotherapy on survival of patients with upper urinary tract urothelial carcinoma clinically involving regional lymph nodes.

Authors:  Kazuhiro Kobayashi; Toshihiro Saito; Yasuo Kitamura; Vladimir Bilim; Tomotaka Toba; Takashi Kawasaki; Noboru Hara; Toshiki Tanikawa; Yoshihiko Tomita
Journal:  Int J Urol       Date:  2015-11-25       Impact factor: 3.369

4.  Effector memory T cells, early metastasis, and survival in colorectal cancer.

Authors:  Franck Pagès; Anne Berger; Matthieu Camus; Fatima Sanchez-Cabo; Anne Costes; Robert Molidor; Bernhard Mlecnik; Amos Kirilovsky; Malin Nilsson; Diane Damotte; Tchao Meatchi; Patrick Bruneval; Paul-Henri Cugnenc; Zlatko Trajanoski; Wolf-Herman Fridman; Jérôme Galon
Journal:  N Engl J Med       Date:  2005-12-22       Impact factor: 91.245

Review 5.  The systemic inflammation-based Glasgow Prognostic Score: a decade of experience in patients with cancer.

Authors:  Donald C McMillan
Journal:  Cancer Treat Rev       Date:  2012-09-17       Impact factor: 12.111

6.  Incidence and natural history of contralateral vesicoureteral reflux in patients presenting with unilateral disease.

Authors:  K E Sparr; A H Balcom; H G Mesrobian
Journal:  J Urol       Date:  1998-09       Impact factor: 7.450

7.  Preoperative risk stratification for cancer-specific survival of patients with upper urinary tract urothelial carcinoma treated by nephroureterectomy.

Authors:  Kazutoshi Fujita; Motohide Uemura; Yoshiyuki Yamamoto; Go Tanigawa; Wataru Nakata; Mototaka Sato; Akira Nagahara; Hiroshi Kiuchi; Yasutomo Nakai; Kiyomi Matsumiya; Seiji Yamaguchi; Norio Nonomura
Journal:  Int J Clin Oncol       Date:  2014-04-18       Impact factor: 3.402

8.  Clinical significance of prognosis using the neutrophil-lymphocyte ratio and erythrocyte sedimentation rate in patients undergoing radical nephroureterectomy for upper urinary tract urothelial carcinoma.

Authors:  Hyun Hwan Sung; Hwang Gyun Jeon; Byong Chang Jeong; Seong Il Seo; Seong Soo Jeon; Han-Yong Choi; Hyun Moo Lee
Journal:  BJU Int       Date:  2014-12-07       Impact factor: 5.588

9.  Negative impact of preoperative platelet-lymphocyte ratio on outcome after hepatic resection for intrahepatic cholangiocarcinoma.

Authors:  Qing Chen; Zhi Dai; Dan Yin; Liu-Xiao Yang; Zheng Wang; Yong-Sheng Xiao; Jia Fan; Jian Zhou
Journal:  Medicine (Baltimore)       Date:  2015-04       Impact factor: 1.889

10.  Comparison of preoperative neutrophil-lymphocyte, lymphocyte-monocyte, and platelet-lymphocyte ratios in patients with upper urinary tract urothelial carcinoma undergoing radical nephroureterectomy.

Authors:  Xin Song; Gui-Ming Zhang; Xiao-Cheng Ma; Lei Luo; Bin Li; Dong-Yue Chai; Li-Jiang Sun
Journal:  Onco Targets Ther       Date:  2016-03-11       Impact factor: 4.147

View more
  10 in total

1.  Is neutrophil-to-lymphocytes ratio a clinical relevant preoperative biomarker in upper tract urothelial carcinoma? A meta-analysis of 4385 patients.

Authors:  Mihai Dorin Vartolomei; Shoji Kimura; Matteo Ferro; Liliana Vartolomei; Beat Foerster; Mohammad Abufaraj; Shahrokh F Shariat
Journal:  World J Urol       Date:  2018-02-21       Impact factor: 4.226

2.  The Prognostic Value of Preoperative Neutrophil-to-Lymphocyte Ratio in Resected Patients with Pancreatic Adenocarcinoma.

Authors:  Le-Ping Fang; Xiao-Yan Xu; Yu Ji; Pu-Wen Huang
Journal:  World J Surg       Date:  2018-11       Impact factor: 3.352

3.  The Prognostic Value of Platelet-to-Lymphocyte Ratio in Urological Cancers: A Meta-Analysis.

Authors:  Dong-Yang Li; Xuan-Yu Hao; Tian-Ming Ma; Hui-Xu Dai; Yong-Sheng Song
Journal:  Sci Rep       Date:  2017-11-13       Impact factor: 4.379

4.  Clinical implications of six inflammatory biomarkers as prognostic indicators in Ewing sarcoma.

Authors:  Yong-Jiang Li; Xi Yang; Wen-Biao Zhang; Cheng Yi; Feng Wang; Ping Li
Journal:  Cancer Manag Res       Date:  2017-09-28       Impact factor: 3.989

Review 5.  Role of Systemic Inflammatory Response Markers in Urothelial Carcinoma.

Authors:  Hyeong Dong Yuk; Ja Hyeon Ku
Journal:  Front Oncol       Date:  2020-08-21       Impact factor: 5.738

6.  The evaluation of monocyte lymphocyte ratio as a preoperative predictor in urothelial malignancies: a pooled analysis based on comparative studies.

Authors:  Xuan Zhu; Shui-Qing Wu; Ran Xu; Yin-Huai Wang; Zhao-Hui Zhong; Lei Zhang; Xiao-Kun Zhao
Journal:  Sci Rep       Date:  2019-04-18       Impact factor: 4.379

7.  Prognostic value of pretreatment lymphocyte-to-monocyte ratio in patients with urologic tumors: A PRISMA-compliant meta-analysis.

Authors:  Jialin Li; Yusheng Cheng; Zhigang Ji
Journal:  Medicine (Baltimore)       Date:  2019-01       Impact factor: 1.889

8.  Prognostic significance of platelet-to-lymphocyte ratio in urothelial carcinoma patients: a meta-analysis.

Authors:  Yuhai Bao; Yin Wang; Xiaodong Li; Mingjun Pan; Hongze Zhang; Zegen Cheng; Xueyi Wang
Journal:  Cancer Cell Int       Date:  2019-11-27       Impact factor: 5.722

9.  Prognostic value of preoperative lymphocyte-related systemic inflammatory biomarkers in upper tract urothelial carcinoma patients treated with radical nephroureterectomy: a systematic review and meta-analysis.

Authors:  Yuan Shao; Wenxia Li; Dongwen Wang; Bo Wu
Journal:  World J Surg Oncol       Date:  2020-10-23       Impact factor: 2.754

10.  Intertwined leukocyte balances in tumours and peripheral blood as robust predictors of right and left colorectal cancer survival.

Authors:  Ramón Cantero-Cid; Karla Marina Montalbán-Hernández; Jenny Guevara; Alejandro Pascual-Iglesias; Elisa Pulido; José Carlos Casalvilla; Cristóbal Marcano; Cristina Barragán Serrano; Jaime Valentín; Gloria Cristina Bonel-Pérez; José Avendaño-Ortiz; Verónica Terrón; Roberto Lozano-Rodríguez; Alejandro Martín-Quirós; Elvira Marín; Eva Pena; Laura Guerra-Pastrián; Eduardo López-Collazo; Luis Augusto Aguirre
Journal:  World J Gastrointest Oncol       Date:  2022-01-15
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.